E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/19/2014 in the Prospect News PIPE Daily.

Second Sight prices $31.5 million initial public stock sale at $9.00

MDB Capital sells 3.5 million common shares to fund corporate purposes

By Devika Patel

Knoxville, Tenn., Nov. 19 – Second Sight Medical Products, Inc. said it priced its $31.5 million initial public offering of stock with a $4.73 million greenshoe. The deal was announced Aug. 12.

The company will sell 3.5 million common shares at $9.00 apiece.

Settlement is expected Nov. 24.

MDB Capital Group, LLC is the bookrunning manager.

Proceeds will be used for general corporate purposes.

The medical device company is based in Sylmar, Calif. The company expects its shares will trade on the Nasdaq under the symbol “EYES.”

Issuer:Second Sight Medical Products, Inc.
Issue:Common stock
Amount:$31.5 million
Greenshoe:$4,725,000
Shares:3.5 million
Price:$9.00
Warrants:No
Bookrunner:MDB Capital Group, LLC
Announcement date:Aug. 12
Pricing date:Nov. 19
Settlement date:Nov. 24
Stock symbol:Nasdaq: EYES

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.